Mechanistic models of humoral kinetics following COVID-19 vaccination
Journal of The Royal Society Interface · 2025-01 · 22 (222)
DOI: 10.1098/rsif.2024.0445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of The Royal Society Interface, online erschienen am 29.01.2025. Verfasst von Daniel Stocks und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering Mathematics and Technology, University of Bristol, Tankard's Close, Bristol, BS8 1TW, UK. Hauptthemen laut MEDLINE: COVID-19, Antibodies, Viral, SARS-CoV-2, COVID-19 Vaccines. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Engineering and Physical Sciences Research Council, Medical Research Council.
Abstract (Originalsprache)
COVID-19 vaccine programmes must account for variable immune responses and waning protection. Existing descriptions of antibody responses to COVID-19 vaccination convey limited information about the mechanisms of antibody production and maintenance. We describe antibody dynamics after COVID-19 vaccination with two biologically motivated mathematical models. We fit the models using Markov chain Monte Carlo to seroprevalence data from 14 602 uninfected individuals in England between May 2020 and September 2022. We analyse the effect of age, vaccine type, number of doses and the interval between doses on antibody production and longevity. We find evidence that individuals over 35 years old twice vaccinated with ChAdOx1-S generate a persistent antibody response suggestive of long-lived plasma cell induction. We also find that plasmablast productive capacity is greater in: younger people than older people (≤4.5-fold change in point estimates); people vaccinated with two doses than one dose (≤12-fold change); and people vaccinated with BNT162b2 than ChAdOx1-S (≤440-fold change). We find the half-life of an antibody to be 23–106 days. Routinely collected seroprevalence data are invaluable for characterizing within-host mechanisms of antibody production and persistence. Extended sampling and linking seroprevalence data to outcomes would enable conclusions about how humoral kinetics protect against disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Engineering Mathematics and Technology, University of Bristol, Tankard's Close, Bristol, BS8 1TW, UK.
- Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield Grove, Bristol, BS8 2BN, UK.
ORCID-Profile: Daniel Stocks, Leon Danon, Ellen Brooks-Pollock
Förderung
- Wellcome Trust
- Engineering and Physical Sciences Research Council
- Medical Research Council
Zitieren
APA
Stocks, D., Thomas, A., Finn, A., Danon, L., & Brooks-Pollock, E. (2025). Mechanistic models of humoral kinetics following COVID-19 vaccination. Journal of The Royal Society Interface, 22(222). https://doi.org/10.1098/rsif.2024.0445
Vancouver
Stocks D, Thomas A, Finn A, Danon L, Brooks-Pollock E. Mechanistic models of humoral kinetics following COVID-19 vaccination. Journal of The Royal Society Interface. 2025;22(222). doi:10.1098/rsif.2024.0445
BibTeX
@article{Stocks2025,
author = {Stocks, Daniel and Thomas, Amy and Finn, Adam and Danon, Leon and Brooks-Pollock, Ellen},
title = {Mechanistic models of humoral kinetics following COVID-19 vaccination},
journal = {Journal of The Royal Society Interface},
year = {2025},
volume = {22},
number = {222},
doi = {10.1098/rsif.2024.0445}
}
EUVIMED